Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements (regression poster) easlfibronostg on June 26, 2026 Category: Publications Tag: LIVERFASt, MASLD, Monitoring, NAFLD Post navigation Previous: Previous post: Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand)Next: Next post: Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients
